Rosemarie Loffredo

Director of Finance/CFO en The Leukemia & Lymphoma Society, Inc. .

Consumer Services

Commercial Services

Perfil

Rosemarie Loffredo is currently the Chief Financial & Administrative Officer at The Leukemia & Lymphoma Society, Inc. She holds an MBA from The Trustees of Columbia University in The City of New York, a graduate degree from Boston College, and an undergraduate degree from Georgetown University.

Cargos activos de Rosemarie Loffredo

Empresas	Cargo	Inicio
The Leukemia & Lymphoma Society, Inc. The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY.	Director of Finance/CFO	24/07/2013

Todos los cargos activos de Rosemarie Loffredo

Formación de Rosemarie Loffredo.

The Trustees of Columbia University in The City of New York	Masters Business Admin
Boston College	Graduate Degree
Georgetown University	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Rosemarie Loffredo.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
The Leukemia & Lymphoma Society, Inc. The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY.	Commercial Services